Post-translational Modification of Protein Biopharmaceuticals
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
From the leading author in the field, known around the world for his work and his authoritative publications, the contents of this book have been selected so as to reflect their relative importance for biopharmaceuticals. As a result, around half of the book is devoted to protein glycosylation, while the remainder is made up of other modifications, such as carboxylation, hydroxylation, sulfation, amidation and proteolytic processing. A final section addresses the latest trend of engineering the modification pattern to improve a given biopharmceutical, presenting several recent case studies of successful posttranslational engineering. This first authoritative overview of the topic is an indispensable guide for drug developers and drug manufacturers with an interest in protein pharmaceuticals.
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Gary Walsh is a senior lecturer in industrial biochemistry at the University of Limerick, Ireland. He combines industrial experience within the pharmaceutical industry with an extensive teaching and academic research background in pharmaceutical biotechno
- Hardcover -
- Erschienen 2012
- Wiley-VCH
- hardcover
- 580 Seiten
- Erschienen 1990
- Springer
- Hardcover
- 496 Seiten
- Erschienen 2013
- World Scientific Publishing...
- hardcover
- 320 Seiten
- Erschienen 2014
- Wiley
- Gebunden
- 420 Seiten
- Erschienen 2007
- Springer
- hardcover
- 395 Seiten
- Erschienen 2003
- Springer
- hardcover
- 560 Seiten
- Erschienen 2010
- Wiley
- hardcover
- 400 Seiten
- Erschienen 2014
- Wiley-Blackwell
- paperback
- 440 Seiten
- Erschienen 2010
- Springer
- hardcover
- 316 Seiten
- Erschienen 2015
- Elsevier
- hardcover
- 770 Seiten
- Erschienen 2015
- CRC Press
- hardcover
- 258 Seiten
- Erschienen 2007
- Wiley-VCH




